Patents by Inventor Matthias Essenpreis
Matthias Essenpreis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220257117Abstract: An ambulatory medical device and a method of communication between medical devices are disclosed. In one embodiment, the medical device includes a module for communication with at least a second medical device wherein the module for communication is adapted to be activated by a value of a physiological parameter of an animal. In one embodiment, the method of the present invention involves a first medical device and at least a second medical device wherein the communication between said medical devices is activated by a value of a physiological parameter of an animal.Type: ApplicationFiled: May 3, 2022Publication date: August 18, 2022Applicant: ROCHE DIABETES CARE, INC.Inventors: Matthias Essenpreis, Ulrich Haueter, Nicole Bernini, Sybille Fankhauser, Sebastiaan La Bastide, Gunnar Meyer Olden, Michael Schoemaker, Kelly Heaton, Joel Jeckelmann
-
Patent number: 11350821Abstract: An ambulatory medical device and a method of communication between medical devices are disclosed. In one embodiment, the medical device includes a module for communication with at least a second medical device wherein the module for communication is adapted to be activated by a value of a physiological parameter of an animal. In one embodiment, the method of the present invention involves a first medical device and at least a second medical device wherein the communication between said medical devices is activated by a value of a physiological parameter of an animal.Type: GrantFiled: August 1, 2007Date of Patent: June 7, 2022Assignee: ROCHE DIABETES CARE, INC.Inventors: Matthias Essenpreis, Ulrich Haueter, Nicole Bernini, Sybille Fankhauser, Sebastiaan La Bastide, Gunnar Meyer Olden, Michael Schoemaker, Kelly Heaton, Joel Jeckelmann
-
Publication number: 20200168328Abstract: A patient information collecting system may include a patient interface device, a patient notification device, an input device for entering patient information, and an information collecting unit having a processor programmed to activate the patient notification device at a specified time prior to occurrence of each of a plurality of scheduled events followed, for each such activation, by presenting instructions via the patient interface device to input to the information collecting unit, via the input device, information specified by the presented instructions and resulting from execution of a corresponding one of the plurality of scheduled events, the plurality of scheduled events including at least two of a scheduled patient glucose measuring event, a scheduled delivery of a diabetes therapy related drug to the patient, a scheduled meal or snack to be consumed by the patient and a scheduled physical activity to be undertaken by the patient.Type: ApplicationFiled: January 30, 2020Publication date: May 28, 2020Inventors: Stefan Weinert, Nicole Bernini, Derek Brandt, Matthias Essenpreis, Kelly Heaton, Joel Jeckelmann, Sebastiaan LaBastide, Gunnar Meyer-Olden, Michael Schoemaker, Robin Wagner
-
Patent number: 10299737Abstract: A method for diabetes care, the method (which also may be referred to as, involve or incorporate at least one of a tool, device or program) allowing for the characterization of the relevance of errors of parameters affecting glucose concentration on a postprandial glucose concentration outcome for a person with diabetes mellitusm, wherein the method involves at least one of sensing, determining, calculating, predicting, describing and communicating the effects of potential errors of parameters affecting glucose concentration on postprandial glucose concentration values within a clinically relevant glucose range.Type: GrantFiled: May 25, 2010Date of Patent: May 28, 2019Assignee: Roche Diabetes Care, IncInventors: Matthias Essenpreis, Michael Schoemaker, Sebastiaan La Bastide, Derek Brandt, Theodor Koschinsky, Sascha Heckermann
-
Publication number: 20150248541Abstract: A system is provided for collecting patient information for diabetes management. The system may comprise a patient interface device, a patient notification device, an input device for entering patient information, and an information collecting unit. The information collecting unit may include a processor electrically coupled to a memory having stored therein at least one algorithm executable by the processor to activate the patient notification device followed by presenting instructions to the patient via the patient interface device to collect specified information from the patient via the input device.Type: ApplicationFiled: May 14, 2015Publication date: September 3, 2015Inventors: Stefan Weinert, Nicole Bernini, Derek Brandt, Matthias Essenpreis, Kelly Heaton, Joel Jeckelmann, Sebastiaan LaBastide, Gunnar Meyer-Olden, Michael Schoemaker, Robin Wagner
-
Patent number: 8849458Abstract: A collection device with a selective display of test results and method thereof are disclosed. A structured collection procedure defining data collection times and the associated context of the collection also defines what information regarding the results of the collection may be viewable by a user performing the structured collection procedure on the device. In this manner, the patient can be monitored according to the structured collection procedure while preventing the patient from modifying his or her behavior based on collection results.Type: GrantFiled: June 18, 2010Date of Patent: September 30, 2014Assignee: Roche Diagnostics Operations, Inc.Inventors: Stefan Weinert, Matthias Essenpreis, Nigel Surridge, Remmert Laan
-
Patent number: 8734347Abstract: Metabolism diseases are evaluated by using a sensor to measure concentration of a medically significant analyte in a human or animal body fluid. The measurement data are correlated with the concentration of a medically significant analyte in body fluid over a time period of at least eight hours. An analytical facility analyzes time intervals within the time period to determine a stability parameter that characterizes the analyte concentration dynamics of change. The analytical facility further analyzes the stability parameters to determine disease-related particularities of metabolism.Type: GrantFiled: May 30, 2008Date of Patent: May 27, 2014Assignee: Roche Diagnostics Operations, Inc.Inventors: Arnulf Staib, Hans-Martin Kloetzer, Matthias Essenpreis
-
Publication number: 20130211849Abstract: A device and method are disclosed for supporting a patient with a disease, comprising a display facility, a user interface, a processor, and a user interface, and with an application module comprising program instructions, which are configured, on executing by the processor to bring about the following: providing medical protocols for diagnostic and/or therapeutic purposes, collecting time information concerning a future event which is a trigger for at least one medical protocol, selecting one of the medical protocols which indicates a group of cohesive protocol events which are spaced apart chronologically over a protocol period in accordance with a protocol regime, monitoring a chronological interval between a current date and the future event, and issuing a user start notice concerning the beginning of the medical protocol at a time which from a chronological point of view lies at least by the protocol period before the future event.Type: ApplicationFiled: August 15, 2012Publication date: August 15, 2013Inventors: Matthias Essenpreis, Dirk Voelkel, Stefan Weinert
-
Publication number: 20110251472Abstract: A system is provided for collecting patient information from which diabetes therapy may be determined. The system may comprise a patient interface device, a patient notification device, an input device for entering patient information, and an information collecting unit. The information collecting unit may include a processor electrically coupled to a memory having stored therein at least one algorithm executable by the processor to activate the patient notification device followed by presenting instructions to the patient via the patient interface device for collecting specified information from the patient via the input device.Type: ApplicationFiled: June 21, 2011Publication date: October 13, 2011Inventors: Stefan Weinert, Nicole Bernini, Derek Brandt, Matthias Essenpreis, Kelly Heaton, Joel Jeckelmann, Sebastiaan LaBastide, Gunnar Meyer-Olden, Michael Schoemaker, Robin Wagner
-
Publication number: 20110152656Abstract: A collection device with a selective display of test results and method thereof are disclosed. A structured collection procedure defining data collection times and the associated context of the collection also defines what information regarding the results of the collection may be viewable by a user performing the structured collection procedure on the device. In this manner, the patient can be monitored according to the structured collection procedure while preventing the patient from modifying his or her behavior based on collection results.Type: ApplicationFiled: June 18, 2010Publication date: June 23, 2011Applicant: ROCHE DIAGNOSTICS OPERATIONS, INC.Inventors: Stefan Weinert, Matthias Essenpreis, Nigel Surridge, Remmert Laan
-
Publication number: 20100235316Abstract: A method for diabetes care, the method (which also may be referred to as, involve or incorporate at least one of a tool, device or program) allowing for the characterization of the relevance of errors of parameters affecting glucose concentration on a postprandial glucose concentration outcome for a person with diabetes mellitusm, wherein the method involves at least one of sensing, determining, calculating, predicting, describing and communicating the effects of potential errors of parameters affecting glucose concentration on postprandial glucose concentration values within a clinically relevant glucose range.Type: ApplicationFiled: May 25, 2010Publication date: September 16, 2010Inventors: Matthias Essenpreis, Michael Schoemaker, Sebastiaan La Bastide, Derek Brandt, Theodor Koschinsky, Sascha Heckermann
-
Patent number: 7782192Abstract: A medical appliance for use on and/or in the body of a user including a transmission unit and an activation switch connected to the transmission unit for activating the transmission unit when an activation signal is received by the activation switch. The invention encompasses systems and processes for transmitting data between a medical appliance and an external appliance, wherein, in some embodiments, the external appliance activates the medical appliance prior to data transmission when the latter is in an idle state.Type: GrantFiled: October 25, 2007Date of Patent: August 24, 2010Assignee: Roche Diagnostics International AGInventors: Joel Jeckelmann, Michael Shoemaker, Sybille Fankhauser, Sebastiaan La Bastide, Gunnar Meyer Olden, Matthias Essenpreis, Nicole Bernini
-
Patent number: 7766831Abstract: A method for diabetes care, the method (which also may be referred to as, involve or incorporate at least one of a tool, device or program) allowing for the characterization of the relevance of errors of parameters affecting glucose concentration on a postprandial glucose concentration outcome for a person with diabetes mellitusm, wherein the method involves at least one of sensing, determining, calculating, predicting, describing and communicating the effects of potential errors of parameters affecting glucose concentration on postprandial glucose concentration values within a clinically relevant glucose range.Type: GrantFiled: March 7, 2008Date of Patent: August 3, 2010Assignee: Roche Diagnostics International AGInventors: Matthias Essenpreis, Michael Schoemaker, Sebastiaan La Bastide, Derek Brandt, Theodor Koschinsky, Sascha Heckermann
-
Patent number: 7731835Abstract: Sensors and a method for detecting an analyte are described. Sensors each have a volume of a hydrophilic medium that retains an amount of analyte proportionate to the concentration of analyte in a biological fluid, electrodes and a redox enzyme in contact with medium, and an electron transfer mediator. The fluid contacts sensors and at initially predetermined intervals intermittently applies a potential to electrode sufficient to oxidize the mediator and sensing current through electrode as a function of the duration of the applied potential. The applied mediator oxidizing applied potential is maintained for a period of time sufficient to determine the rate of change of current with time through electrode. The current flow is correlated with the current flow for known concentrations of the analyte in medium.Type: GrantFiled: January 19, 2005Date of Patent: June 8, 2010Assignee: Roche Diagnostics Operations, Inc.Inventors: Harvey B. Buck, Matthias Essenpreis
-
Patent number: 7499738Abstract: Assembly and method for measuring the concentration of an analyte in a biological matrix. The assembly includes an implantable optical-sensing element that comprises a body, and a membrane mounted on the body in a manner such that the membrane and the body define a cavity. The membrane is permeable to the analyte, but is impermeable to background species in the biological matrix. A refractive element is positioned in the cavity. A light source transmits light of a first intensity onto the refractive element, and a light detector receives light of a second intensity that is reflected from the cavity. A controller device optically coupled to the detector compares the first and second light intensities, and relates the intensities to analyte concentration.Type: GrantFiled: April 27, 2005Date of Patent: March 3, 2009Assignee: Roche Diagnostics Operations, Inc.Inventors: Martin Gerber, Matthias Essenpreis, Wolfgang Petrich
-
Publication number: 20080262333Abstract: Metabolism diseases are evaluated by using a sensor to measure concentration of a medically significant analyte in a human or animal body fluid. The measurement data are correlated with the concentration of a medically significant analyte in body fluid over a time period of at least eight hours. An analytical facility analyzes time intervals within the time period to determine a stability parameter that characterizes the analyte concentration dynamics of change. The analytical facility further analyzes the stability parameters to determine disease-related particularities of metabolism.Type: ApplicationFiled: May 30, 2008Publication date: October 23, 2008Inventors: Arnulf Staib, Hans-Martin Kloetzer, Matthias Essenpreis
-
Publication number: 20080242963Abstract: A method for diabetes care, the method (which also may be referred to as, involve or incorporate at least one of a tool, device or program) allowing for the characterization of the relevance of errors of parameters affecting glucose concentration on a postprandial glucose concentration outcome for a person with diabetes mellitusm, wherein the method involves at least one of sensing, determining, calculating, predicting, describing and communicating the effects of potential errors of parameters affecting glucose concentration on postprandial glucose concentration values within a clinically relevant glucose range.Type: ApplicationFiled: March 7, 2008Publication date: October 2, 2008Applicant: Disetronic Licensing AGInventors: Matthias Essenpreis, Michael Schoemaker, Sebastiaan La Bastide, Derek Brandt, Theodor Koschinsky, Sascha Heckermann
-
Publication number: 20080177149Abstract: A system is provided for collecting patient information from which diabetes therapy may be determined. The system may comprise a patient interface device, a patient notification device, an input device for entering patient information, and an information collecting unit. The information collecting unit may include a processor electrically coupled to a memory having stored therein at least one algorithm executable by the processor to activate the patient notification device followed by presenting instructions to the patient via the patient interface device for collecting specified information from the patient via the input device.Type: ApplicationFiled: June 16, 2006Publication date: July 24, 2008Inventors: Stefan Weinert, Nicole Bernini, Derek Brandt, Matthias Essenpreis, Kelly Heaton, Joel Jeckelmann, Sebastiaan LaBastide, Gunnar Meyer-Olden, Michael Schoemaker, Robin Wagner
-
Publication number: 20080129486Abstract: A medical appliance for use on and/or in the body of a user including a transmission unit and an activation switch connected to the transmission unit for activating the transmission unit when an activation signal is received by the activation switch. The invention encompasses systems and processes for transmitting data between a medical appliance and an external appliance, wherein, in some embodiments, the external appliance activates the medical appliance prior to data transmission when the latter is in an idle state.Type: ApplicationFiled: October 25, 2007Publication date: June 5, 2008Inventors: Joel Jeckelmann, Michael Schoemaker, Sybille Frankhauser, Sebastiaan La Bastide, Gunnar Meyer Olden, Matthias Essenpreis, Nicole Bernini
-
Publication number: 20080033255Abstract: An ambulatory medical device and a method of communication between medical devices are disclosed. In one embodiment, the medical device includes a module for communication with at least a second medical device wherein the module for communication is adapted to be activated by a value of a physiological parameter of an animal. In one embodiment, the method of the present invention involves a first medical device and at least a second medical device wherein the communication between said medical devices is activated by a value of a physiological parameter of an animal.Type: ApplicationFiled: August 1, 2007Publication date: February 7, 2008Inventors: Matthias Essenpreis, Ulrich Haueter, Nicole Bernini, Sybille Fankhauser, Sebastiaan La Bastide, Gunnar Meyer Olden, Michael Schoemaker, Kelly Heaton, Joel Jackelmann